サインイン

Brian Hetrick

Center for Infectious Disease Research,
School of Systems Biology,
Center for Infectious Disease Research, School of Systems Biology

George Mason University

BIOGRAPHY

Brian Hetrick has not added Biography.

If you are Brian Hetrick and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity.

Viruses Dec, 2020 | Pubmed ID: 33396594

A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro.

Cell & bioscience May, 2021 | Pubmed ID: 34051873

Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors.

Viruses May, 2021 | Pubmed ID: 34064525

Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs.

Cell reports methods Mar, 2022 | Pubmed ID: 35229082

INSTITUTIONS

George Mason University

JOVE ARTICLES

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Linda Chilin¹,

Brian Hetrick¹,

Yuntao Wu¹

¹Center for Infectious Disease Research, School of Systems Biology, George Mason University

Immunology and Infection

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Brian Hetrick

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Center for Infectious Disease Research,School of Systems Biology,Center for Infectious Disease Research, School of Systems Biology

George Mason University

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Center for Infectious Disease Research,
School of Systems Biology,
Center for Infectious Disease Research, School of Systems Biology